Skip to main
ABMD
ABMD logo

ABIOMED (ABMD)

$0.00

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Buy ABIOMED (ABMD) Stock

About ABIOMED (ABMD)

ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA.
Market cap$17.18B
Today's volume
Revenue (TTM)
Avg. daily volume1.43M
EBITDA (TTM)
Open
Price / earnings ratio65.48x
Today's range
Debt / equity
52 week range$219.85 - $381.99
5 year debt / equity0.3x
Beta (LTM)1.26x
Interest coverage
Dividend & yield$0.00 (0.00%)
Current ratio
Ex-dividend date
Next earningsNov 1, 2022
Dividend payable date

Frequently Asked Questions (FAQ)

As of Jun 12, 2025, the market cap for ABIOMED stock is $17.19B

The current P/E ratio for ABIOMED stock is 65.48

The 52-week high for ABIOMED stock is $381.99. The current ABIOMED stock price $undefined is 100.00% below its 52-week high

The 52-week low for ABIOMED stock is $219.85. The current ABIOMED stock price $undefined has increased 100.00% from its 52-week low

No, the ABIOMED stock does not pay dividends to its shareholders

How to buy ABIOMED stock on Public

  1. 1

    Sign up for a brokerage account on Public

    It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.

  2. 2

    Add funds to your Public account

    There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.

  3. 3

    Choose how much you'd like to invest in ABIOMED stock

    Navigate to the Explore page. Then, type ABIOMED into the search bar. When you see ABIOMED stock appear in the results, tap it to open up the purchase screen.

  4. 4

    Manage your investments in one place

    You can find your newly purchased ABIOMED stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.

ABIOMED Stock Earnings

The value each ABMD share was expected to gain vs. the value that each ABMD share actually gained.

ABIOMED (ABMD) reported Q2 2023 earnings per share (EPS) of $1.30, beating estimates of $1.04 by 25.00%. In the same quarter last year, ABIOMED's earnings per share (EPS) was $1.03. ABIOMED is expected to release next earnings on 11/01/2022, with an earnings per share (EPS) estimate of $0.

Buy ABIOMED (ABMD) Stock

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.